Other languages Edwards Lifesciences Corporation Berne S.E.

Equities

001065343

US28176E1082

Delayed Berne S.E. Other stock markets 09:30:02 05/04/2024 pm IST			5-day change	1st Jan Change
83.18 ^CHF	+1.86%		-.--%	+20.95%

20/06	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT
17/06	Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	21/06
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03/06
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06
EE.UU. - Valores a seguir en Wall Street (actualizado)	31/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	14/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	02/05
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	01/05
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	26/04
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	26/04
EE.UU. - Valores a seguir en Wall Street	26/04
Edwards Lifesciences : relève ses prévisions de ventes après un bon premier trimestre	26/04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST